Washington House Bill HB1038

Washington 2025-2026 Regular Session

• Introduced: 1/13/25
• Refer: 1/13/25

Caption

Prohibiting puberty blocking medications, cross-sex hormones, and gender transition surgeries for minors.

Impact

If enacted, HB1038 would significantly alter the legal landscape surrounding the provision of gender-affirming healthcare for minors. It would impose restrictions on the medical discretion of healthcare providers, requiring them to refrain from prescribing or administering hormone therapies or surgeries. This statute could lead healthcare professionals to reconsider the treatment options they offer to minors and could result in a decrease in access to these services for transgender youth, thus impacting their mental health and well-being.

Summary

House Bill 1038 seeks to prohibit the use of puberty blocking medications, cross-sex hormones, and gender transition surgeries for minors. The bill is aimed at regulating gender affirming medical treatments in a bid to ensure that minors do not undergo irreversible changes to their bodies during a formative age. Proponents of the bill argue that it is necessary to protect young people from making decisions that they may later regret, emphasizing the need for parental guidance and consent when it comes to such significant medical interventions.

Contention

The bill has sparked considerable debate among lawmakers, healthcare providers, and advocacy groups. Supporters, largely from conservative factions, argue that the bill is a necessary safeguard, while opponents—comprising numerous medical professionals and LGBTQ+ advocates—argue that it represents an infringement on personal freedoms and the right to pursue medically necessary treatments. They contend that denying access to gender-affirming care can exacerbate mental health issues among transgender minors, further complicating their development and quality of life.